Genmab A (GMAB) Net Margin (2018 - 2026)
Genmab A (GMAB) posted Net Margin of 634.15% for Q1 2026, up 193.53% on a QoQ basis from 216.04% in Q3 2025, and down 10655.0% year-over-year from N/an in Q1 2025.
Genmab A (GMAB) Net Margin (2018 - 2026) Analysis & Trends
Genmab A's Net Margin history runs 5 years deep, the most recent figure standing at 634.15% for Q1 2026.
- Quarterly Net Margin fell 10655.0% year-over-year to 634.15% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 204.63% (down 3977.0% YoY) and the FY2025 annual result came in at 25.89%, down 13871.0% from the prior year.
- Net Margin was 634.15% for Q1 2026 at Genmab A, up from 216.04% in the prior quarter.
- Across five years, Net Margin topped out at 781.59% in Q1 2024 and bottomed at 40.23% in Q2 2024.
- A 3-year average of 381.64% and a median of 218.06% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2025 — Net Margin jumped 44 bps — and 2026, when it tumbled 10655 bps.
- Genmab A's Net Margin stood at 218.06% in 2024, then fell by 1 bps to 216.04% in 2025, then surged by 194 bps to 634.15% in 2026.
- Business Quant data shows GMAB's Net Margin at 634.15% in Q1 2026, 216.04% in Q3 2025, and 40.67% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | 634.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 634.15% |
| Sep 30, 2025 | 216.04% |
| Jun 30, 2025 | 40.67% |
| Mar 31, 2025 | 740.70% |
| Sep 30, 2024 | 218.06% |
| Jun 30, 2024 | 40.23% |
| Mar 31, 2024 | 781.59% |
| Dec 31, 2019 | 18.52% |
| Sep 30, 2019 | 67,248,452,652,513.27% |
| Dec 31, 2018 | 0.00% |